ACTRN12612001194853
Completed
Phase 3
The CNS sub-study of a randomised, double-blind, placebo-controlled, clinical trial to compare the safety and efficacy of reduced dose efavirenz (EFV) with standard dose EFV plus 2N(t)RTI in antiretroviral-naive HIV-infected individuals over 96 weeks
Kirby Institute, University of New South Wales0 sites40 target enrollmentNovember 13, 2012
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Kirby Institute, University of New South Wales
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All subjects entering into the main study protocol at participating centres will be eligible to enter this sub\-study
Exclusion Criteria
- •Existing neurological disease which in the opinion of the
- •investigator would be a contra\-indication to lumbar
- •puncture examination
- •CNS opportunistic infections in the past 12 weeks
- •Bacterial or viral meningitis in the past 12 weeks
- •Head injury requiring medical assessment in the past 12 weeks
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
eurological risk factors in infants having non-cardiac surgery, and their relationship to growth and neurodevelopmental outcomeCongenital diaphragmatic herniaOesophageal AtresiaAnterior abdominal wall defect (Gastroschisis or exomphalos)Neurological - Other neurological disordersACTRN12610000156088Royal Children's Hospital50
Completed
Phase 4
Evaluating the Effect of Epidural Clonidine as an Adjuvant to 0.5% Bupivacaine intrathecally in Combined Spinal Epidural Anaesthesia in lower limb orthopedic surgery.Health Condition 1: O- Medical and SurgicalCTRI/2022/04/042029Sawai Man Singh Medical College and Hospitals62
Not yet recruiting
Phase 4
Study for assessing technique for pain relief in children undergoing cleft lip surgery.Health Condition 1: Q375- Cleft hard and soft palate with unilateral cleft lipCTRI/2023/03/050425SRM
Active, not recruiting
Phase 1
The Amiloride Clinical Trial in Optic Neuritis - does amiloride protect nerve cells from injury after an episode of optic nerve inflammation?Optic NeuritisMedDRA version: 14.1 Level: PT Classification code 10030942 Term: Optic neuritis System Organ Class: 10029205 - Nervous system disordersTherapeutic area: Diseases [C] - Nervous System Diseases [C10]EUCTR2012-004980-39-GBniversity of Oxford46
Recruiting
Phase 3
Macrolide treatment of Non-Eosinophilic AsthmaACTRN12605000318684Hunter New England Area Health Service64